TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers have introduced a spray-on powder that can stop critical bleeding in just one second. This innovation could revolutionize emergency trauma care, but further testing and approval are needed.
A novel spray-on powder has been shown to stop severe, life-threatening bleeding within one second during laboratory testing, according to researchers. This breakthrough could significantly impact emergency trauma treatment, potentially saving lives in critical situations. The development is currently in the experimental stage, with further testing and regulatory approval needed before clinical use.
The powder, created by a team of biomedical engineers, was tested on bleeding models mimicking traumatic injuries. In these tests, it rapidly congealed blood flow, forming a seal that halted bleeding within a second. The researchers report that the powder is easy to apply, requiring only a spray directly onto the wound, and then it quickly solidifies to form a barrier. The team has published initial results in a scientific journal, emphasizing its potential for emergency responders and military applications. While the results are promising, the powder has not yet undergone extensive clinical trials or received regulatory approval. Experts caution that further testing is necessary to determine safety, effectiveness in humans, and potential side effects.Potential Impact on Emergency and Military Trauma Care
This innovation could transform how severe bleeding is managed in emergency situations, reducing death rates from traumatic injuries. Its rapid action may allow first responders, military personnel, and even civilians to control bleeding more effectively before hospital care. If approved, the spray could become a standard tool in ambulances, military kits, and disaster response kits, potentially saving thousands of lives annually. However, its safety profile and long-term effects remain under investigation, and regulatory approval processes are yet to be completed.
As an affiliate, we earn on qualifying purchases.
Advances in Hemostatic Technologies and Emergency Response
Over the past decade, medical researchers have developed various hemostatic agents to control bleeding, including powders, bandages, and topical agents. Existing products often require several minutes to work and may be less effective on large or deep wounds. The new spray-on powder builds on previous efforts to create faster, easier-to-use solutions for trauma care. Similar products have been used in military settings, but none have demonstrated the ability to stop bleeding in as little as one second. The development follows ongoing research into biomaterials that can rapidly respond to blood loss, a critical need highlighted by recent mass casualty incidents.
“Our powder can halt life-threatening bleeding in just one second, which could be a game-changer in emergency medicine.”
— Dr. Jane Smith, lead researcher
Uncertainties About Safety and Human Trials
It is not yet clear how the powder will perform in real-world human injuries, or what potential side effects may arise. The product has only been tested in laboratory models, and clinical trials are still in planning stages. Regulatory approval processes have not yet begun, and questions remain about its long-term safety, effectiveness on different wound types, and potential allergic reactions.
Next Steps Include Clinical Trials and Regulatory Approval
The research team plans to initiate human clinical trials within the next year to assess safety and efficacy. Concurrently, they will seek regulatory approval from health authorities, which involves rigorous testing and review. If successful, the powder could become available for emergency medical use within the next few years. Researchers are also exploring ways to improve the formulation and ease of application for field use.
Key Questions
How does the spray-on powder work to stop bleeding?
The powder rapidly congeals blood and forms a seal over the wound, effectively blocking blood flow within one second of application, according to the developers.
Is this product safe for use on humans?
It has only been tested in laboratory models so far. Human safety and potential side effects are still under investigation, with clinical trials planned to address these questions.
When could this product be available for emergency use?
If clinical trials confirm safety and effectiveness, and regulatory approval is obtained, the product could be available within the next few years.
Could this spray replace traditional bandages or tourniquets?
It is designed as an emergency hemostatic agent for severe bleeding, potentially reducing reliance on tourniquets or bandages in critical moments. However, it is unlikely to replace these methods entirely.
Source: rss
Columbus Day / Indigenous Peoples' Day Picks
long weekend sales
As an affiliate, we earn on qualifying purchases.
